ARVN
Arvinas Inc. Healthcare - Biotechnology Investor Relations →
Arvinas Inc. (ARVN) closed at $10.94 as of 2026-03-20, trading 57.4% below its 200-week moving average of $25.69. This places ARVN in the extreme value zone. The stock is currently moving closer to the line, down from -52.9% last week. The 14-week RSI sits at 42, indicating neutral momentum.
A big spike in selling this week — 2.0x the usual volume, and the price dropped. Sometimes this kind of heavy selling marks the end of a decline. The idea is that the last reluctant holders have finally sold, leaving fewer sellers left to push the price lower.
Over the past 342 weeks of data, ARVN has crossed below its 200-week moving average 6 times. On average, these episodes lasted 36 weeks. Historically, investors who bought ARVN at the start of these episodes saw an average one-year return of +27.2%.
With a market cap of $703 million, ARVN is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -16.2%. The stock trades at 1.6x book value.
Share count has increased 19.4% over three years, indicating dilution.
Over the past 6.6 years, a hypothetical investment of $100 in ARVN would have grown to $57, compared to $241 for the S&P 500. ARVN has returned -8.2% annualized vs 14.3% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: ARVN vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After ARVN Crosses Below the Line?
Across 6 historical episodes, buying ARVN when it crossed below its 200-week moving average produced an average return of +14.3% after 12 months (median -35.0%), compared to +16.2% for the S&P 500 over the same periods. 33% of those episodes were profitable after one year. After 24 months, the average return was +41.3% vs +39.2% for the index.
Each line shows $100 invested at the moment ARVN crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
ARVN has crossed below its 200-week MA 6 times with an average 1-year return of +27.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Sep 2019 | Oct 2019 | 3 | 21.8% | +25.6% | -43.0% |
| Aug 2020 | Dec 2020 | 17 | 25.3% | +241.7% | -59.0% |
| May 2022 | Jul 2022 | 9 | 17.2% | -44.6% | -76.1% |
| Aug 2022 | Nov 2022 | 12 | 13.8% | -41.1% | -76.0% |
| Nov 2022 | Feb 2024 | 63 | 71.6% | -45.8% | -72.9% |
| Feb 2024 | Ongoing | 109+ | 84.5% | Ongoing | -76.7% |
| Average | 36 | — | +27.2% | — |
Frequently Asked Questions
Is ARVN below its 200-week moving average?
Yes. As of 2026-03-20, Arvinas Inc. (ARVN) is trading 57.4% below its 200-week moving average of $25.69. The current price is $10.94.
What is ARVN's 200-week moving average price?
Arvinas Inc.'s 200-week moving average is $25.69 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when ARVN drops below its 200-week moving average?
ARVN has crossed below its 200-week moving average 6 times in our data. On average, buying at that moment produced a one-year return of +27.2%. These dips have historically been decent entry points. These episodes lasted 36 weeks on average.
Is ARVN a good value right now?
Here's what our data says about ARVN as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 42. Free cash flow is currently negative. Return on equity is -16.2%. Price-to-book is 1.6x. This is not a buy or sell recommendation — always do your own research.
How does ARVN compare to the S&P 500?
Over the past 6.6 years, $100 invested in ARVN would have grown to $57, compared to $241 for the S&P 500. That's -8.2% annualized vs 14.3% for the index. ARVN has underperformed the broader market over this period.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20